Naoya Kawashima - Concepedia

Concepedia

Author

Naoya Kawashima

Taisho Pharmaceutical (Japan)

Also Known As

NAOYA KAWASHIMA, Naoya KAWASHIMA, Naoya Kawashima

48

Publications

3.5K

Citations

20

H-Index

49

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)Hoshi University Nihon Nohyaku (Japan)Toray Industries, Inc. (Japan)

NK

About

Naoya Kawashima is an author at Taisho Pharmaceutical (Japan) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	2.7K
2	Health Sciences	9	9	253
3	Social Sciences	7	7	2.3K
4	Anesthesia	2	2	42
5	Allergy	1	1	27

Naoya Kawashima

×

28

Publications

3.5K

Citations

20

H-Index

	Year	Citations
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1 Kohichi Tanaka, Kei Watase, Toshiya Manabe, Science NeurophysiologyPhysiologyAstrocytic Glutamate TransporterNeuropharmacologySocial Sciences	1997	1.8K
Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice Kei Watase, Kouichi Hashimoto, Masanobu Kano, European Journal of Neuroscience	1998	408
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota, Neuropharmacology Antidepressant-like ActivityPsychoactive DrugPsychiatryFunctional SelectivityMedicine	2003	250
Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001 Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima, Journal of Pharmacology and Experimental Therapeutics	1999	153
AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist Jun-ichi Karasawa, Toshiharu Shimazaki, Naoya Kawashima, Brain Research PsychiatryNeurophysiologyMedicineFunctional SelectivityNeurotransmitter	2005	130
Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents Shigeyuki Chaki, Naoya Kawashima, Yoshiko Suzuki, European Journal of Pharmacology Substance AbusePsychoactive DrugBehavioral NeuroscienceAddictionAmphetamine-regulated Transcript Peptide	2003	97
Effect of 20-HETE Inhibition on Infarct Volume and Cerebral Blood Flow after Transient Middle Cerebral Artery Occlusion Marija Renić, Judith A. Klaus, Tomohiro Omura, Journal of Cerebral Blood Flow & Metabolism	2008	96
Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors Naoya Kawashima, Jun-ichi Karasawa, Toshiharu Shimazaki, Neuroscience Letters NeurophysiologyMedicineFunctional SelectivityNeuropeptide ReceptorNeuropharmacology	2005	65
Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice Junzo Kamei, Naoya Kawashima, Yutaka Kasuya Brain Research InflammationAnti-inflammatoryPain MedicineMedicineDiabetic Mice	1992	48
Pain threshold, learning and formation of brain edema in mice lacking the angiotensin II type 2 receptor Takashi Sakagawa, Shigeru Okuyama, Naoya Kawashima, Life Sciences Health SciencesAcute PainNeurophysiologyPain MedicinePhysiology	2000	48

Page 1